Twist Bioscience SVP sells 39,404 shares

Twist Bioscience Corp senior vice president of human resources Paula Green reported an open-market sale of common stock.

Rhea-AI Filing Summary

Twist Bioscience Corp senior vice president of human resources Paula Green reported an open-market sale of common stock. On February 17, 2026, she sold 39,404 shares at a weighted average price of $52.40 per share, and held 126,041 shares afterward.

Insider Trade Summary

Net Seller: 39,404 shares

Net Sell 1 txn

Insider Green Paula

Role SVP of Human Resources

Sold 39,404 shs ($2.06M)

Type	Security	Shares	Price	Value
Sale	Common Stock	39,404	$52.40	$2.06M

Holdings After Transaction: Common Stock — 126,041 shares (Direct)

Footnotes (1)

1. F1. Represents the weighted average sales price per share. The shares sold at prices ranging from $52.27 to $52.64 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Paula Green report for Twist Bioscience (TWST)?

Paula Green reported selling common stock of Twist Bioscience in an open-market transaction. The filing shows one sale of 39,404 shares of common stock on February 17, 2026, as an open-market or private transaction under transaction code S.

How many Twist Bioscience (TWST) shares did Paula Green sell and at what price?

Paula Green sold 39,404 shares of Twist Bioscience common stock. The weighted average sales price was $52.40 per share, with individual trade prices ranging from $52.27 to $52.64, according to the detailed pricing footnote included in the Form 4 filing.

What is Paula Green’s remaining Twist Bioscience (TWST) share ownership after the sale?

After the reported sale, Paula Green directly owned 126,041 shares of Twist Bioscience common stock. This figure reflects her holdings immediately following the February 17, 2026 open-market transaction disclosed in the Form 4 insider trading report.

What transaction code was used for Paula Green’s Twist Bioscience (TWST) trade?

The transaction was reported with code S, indicating a sale in an open market or private transaction. The Form 4 classifies it as a non-derivative transaction in Twist Bioscience common stock executed on February 17, 2026 by Paula Green.

Was Paula Green’s Twist Bioscience (TWST) transaction a buy or sell?

The transaction was a sell. The Form 4 identifies it as an open-market sale of 39,404 shares of Twist Bioscience common stock, with the transaction direction explicitly categorized as a sell and no corresponding purchase transactions reported.

How is the sale price range for Paula Green’s Twist Bioscience (TWST) shares described?

The filing reports a weighted average sales price of $52.40 per share. A footnote explains the shares were sold in multiple trades at prices between $52.27 and $52.64, with full trade-by-trade details available upon request to authorized parties.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 04:05 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Green Paula

(Last) (First) (Middle)

C/O TWIST BIOSCIENCE CORPORATION

681 GATEWAY BLVD.

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Twist Bioscience Corp [ TWST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP of Human Resources

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/17/2026		S		39,404(1)	D	$52.4	126,041	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the weighted average sales price per share. The shares sold at prices ranging from $52.27 to $52.64 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Remarks:

	/s/ Kendra Fox, as Attorney-in-Fact for Paula Green	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.